Please login to the form below

Not currently logged in
Email:
Password:

Deal Watch table for January 2014

Deal Watch tableTable listing all the major pharma mergers, acquisitions and collaborations in the past month

Pharma deals during January 2015

deal watch image mergers acquisitions pharmaDeal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Gathering pace: adaptive pathways

EU flagEMA looks at how the model could work in practice and picks first drugs for its pilot project

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Webinars

Is co-creation the key to customer-centricity?

As pharma grapples with the need to becomemore doctor- and patient-centric, can co-creation help it better engage andconnect with its audience by redefining industry relationships with physicians and improve patient

Holistic market access and the importance of early engagement

Holistic market accessThere are two key elements in any successful strategy: knowing what to do, and knowing when to do it. Yet in terms of market access, there appears to be a

Digital: Fallacy or the Future Face of Pharma Marketing?

Digital: Fallacy or the Future Face of Pharma MarketingReach is one thing, trust is another. Digital channels may well be are growing in reach, but recent research from Cello Health Insight found that when it comes to trust,

UK payer perspectives: Is big data the future of market access?

'UK payer perspectives: Is big data the future of market access?’ will feature Paul Sutton, Director of Outcomes and Value, Commercial UK at Quintiles and Dr Junaid Bajwa, a GP

Country reports

Is obesity really a problem in Brazil?

Obesity is on the rise in low- and middle-income countries, particularly in urban settings

Turkey: A growing pharma market with huge potential

The Turkish biopharma market offers many opportunities - if it can overcome its sustainability challenge

Creating a 21st century life sciences ecosystem

UK life sciences minister George FreemanThe UK’s life sciences minister on how government and pharma can encourage NHS uptake and innovation

Video

The challenge of antimicrobial resistance

Cubist Patrick-Vink Cubist's Patrick Vink on the company's ambitions in anti-infectives

Switching to a virtual healthcare system

babylon virtual health service Ali Parsa, CEO and founder of babylon, discusses the benefits of conducting healthcare consultations via a smartphone

The role of artificial intelligence in healthcare

Watson on jeopardy IBM's Amer Fasihi on the rise of Watson

White papers

E-detailing content wow factor in 2015

Many companies are reporting that the iPad novelty has worn off and healthcare professionals are demanding more than just another animation presented on a mobile device. So what exactly are

Free White Paper: Multichannel Marketing for Pharma

Transitioning successfully to multichannel marketing takes careful planning. When done right, pharma can deliver a personalised experience for each customer. Download our white paper to learn how

How to confirm customer understanding in e-detailing

Done right, e-detailing takes away the guesswork in your marketing.

The benefits of a customer-centred approach to pharma marketing

The realisation that good customer experience is important for the success of a business is certainly old news, even in the pharma industry. Despite this understanding however, pharma still doesn’t

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Munro & Forster

At Munro & Forster we deliver real and lasting impact for our clients.We specialise in health and wellbeing, education and...